Pharmacology of Ischemia–Reperfusion. Translational Research Considerations

REFERENCES

• Castaneda MP, Swiatecka-Urban A, Mitsnefes MM, et al. Activation of mitochondrial apoptotic pathways in human renal allografts after ischemia reperfusion injury. Transplantation. 2003;76(1):50–54.
   PubMed Web of Science ®Google Scholar
• Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006;17(6):1503–1520.
   PubMed Web of Science ®Google Scholar
• Kennedy SE, Erlich JH. Murine renal ischaemia-reperfusion injury. Nephrology (Carlton). 2008;13(5):390–396.
   PubMed Web of Science ®Google Scholar
• Schoenberg MH, Beger HG. Reperfusion injury after intestinal ischemia. Crit Care Med. 1993;21(9):1376–1386.
   PubMed Web of Science ®Google Scholar
• Yun Y, Duan WG, Chen P, et al. Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc. 2009;41(9):3597–3602.
   PubMed Web of Science ®Google Scholar
• Hertle L, Garthoff B. Calcium channel blocker nisoldipine limits ischemic damage in rat kidney. J Urol. 1985;134(6):1251–1254.
   PubMed Web of Science ®Google Scholar
• Shapiro JI, Cheung C, Itabashi A, et al. The effect of verapamil on renal function after warm and cold ischemia in the isolated perfused rat kidney. Transplantation. 1985;40(6):596–600.
   PubMed Web of Science ®Google Scholar
• Niños JA, Toledo AH, López-Neblina F, et al. “Effects of dantrolene on ischemia–reperfusion injury in animals models: a review of outcomes in Heart, Brain, Liver, and Kidney”. Universidad estatal de Michigan. J Surg Res. 2010.
   Google Scholar
• Schreinemachers MC, Doorschodt BM, Florquin S, et al. Comparison of preservation solutions for washout of kidney grafts: an experimental study. Transplant Proc. 2009;41(10):4072–4079.
   PubMed Web of Science ®Google Scholar
• Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124–1136.
   PubMed Web of Science ®Google Scholar
• Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87(3):893–899.
   PubMed Web of Science ®Google Scholar
• Cohen M, Downey JM. Precondicionamiento isquémico: de los mecanismos básicos a las aplicaciones clínicas. Revista Argentina de Cardiología. 2000;62(2):285–299.
   Google Scholar
• Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol. 2001;41:775–787.
   PubMed Web of Science ®Google Scholar
• Zaugg M, Lucchinetti E, Uecker M, et al.. Anaesthetics and cardiac preconditioning. Part I. Signalling and cytoprotective mechanism. Br J Anaesth. 2003;91:551–565.
   PubMed Web of Science ®Google Scholar
• Minamino T, Kitakaze M, Morioka T, et al. Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol. 1996;270(1 Pt 2):H238–H244.
   PubMed Web of Science ®Google Scholar
• Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106(23):2881–2883.
   PubMed Web of Science ®Google Scholar
• Dong JH, Liu YX, Ji ES, et al. Limb ischemic preconditioning reduces infarct size following myocardial ischemia–reperfusion in rats. Sheng Li Xue Bao. 2004;56(1):41–46.
   PubMedGoogle Scholar
• Gho BC, Schoemaker RG, Van den Doel MA, et al. Myocardial protection by brief ischemia in noncardiac tissue. Circulation. 1996;94(9):2193–2200.
   PubMed Web of Science ®Google Scholar
• Lang SC, Elsasser A, Scheler C, et al. Myocardial preconditioning and remote renal preconditioning-identifying a protective factor using proteomic methods?. Basic Res Cardiol. 2006;101(2):149–158.
   PubMed Web of Science ®Google Scholar
• Dong HL, Zhang Y, Su BX, et al. Limb remote ischemic preconditioning protects the spinal cord from ischemia–reperfusion injury: a newly identified nonneuronal but reactive oxygen species-dependent pathway. Anesthesiology 2010;112(4):881–891.
   PubMed Web of Science ®Google Scholar
• Lazaris AM, Maheras AN, Vasdekis SN, et al. Protective effect of remote ischemic preconditioning in renal ischemia/ reperfusion injury, in a model of thoracoabdominal aorta approach. J Surg Res. 2009;154(2):267–273.
   PubMed Web of Science ®Google Scholar
• Oehmann C, Benz S, Drognitz O, et al. Remote preconditioning reduces microcirculatory disorders in pancreatic ischemia/reperfusion injury. Pancreas 2007;35(4): e45–e50.
   Google Scholar
• Takagi H, Manabe H, Kawai N, et al. Review and meta-analysis of randomized controlled clinical trials of remote ischemic preconditioning in cardiovascular surgery. Am J Cardiol. 2008;102(11):1487–1488.
   PubMed Web of Science ®Google Scholar
• Zhou W, Zeng D, Chen R, et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol. 2010;31(1):22–29.
   PubMed Web of Science ®Google Scholar
• Hu S, Dong HL, Li YZ, et al. Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial. J Neurosurg Anesthesiol. 2010;22(1):46–52.
   PubMed Web of Science ®Google Scholar
• Ali ZA, Callaghan CJ, Lim E, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation. 2007;116(11-supl):I98–I105.
   PubMed Web of Science ®Google Scholar
• Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: Part 1. Circulation. 2001;104(24):2981–2989.
   PubMed Web of Science ®Google Scholar
• Kis A, Vegh A, Papp J y col. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase. Br J Pharmacol. 1999;127:1545–1550.
   PubMed Web of Science ®Google Scholar
• Parra tt JR. Protection of the hearth by ischemic preconditioning: Mechanisms and possibilities for pharmacological exploitation. Trenda Pharmacol Sci. 1994;15: 19–25.
   PubMed Web of Science ®Google Scholar
• Bolli R, Dawn B, Tang X-L y col. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 1998;93:325–338.
   PubMed Web of Science ®Google Scholar
• Wu Z-K, Livainen T, Pehkonen E, et al. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularization. Circulation. 2002;106(24):3091–3096.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Yadav S, Sindram D, et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232(2):155–162.
   PubMed Web of Science ®Google Scholar
• Atalla SL, Toledo-Pereyra LH, MacKenzie GH, et al. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation. 1985;40(6):584–590.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Takeuchi H, Kakita T, et al. The involvement of the intracellular superoxide production system in hepatic ischemia–reperfusion injury. In vivo and in vitro experiments using transgenic mice manifesting excessive CuZn–SOD activity. Free Radic Biol Med. 2000;29(8):756–763.
   PubMed Web of Science ®Google Scholar
• Bulger E, Maier R. Antioxidants in critical illness. Arch Surg. 2001;136(10):1201–1207.
   PubMedGoogle Scholar
• Origassa CS, Camara NO. Cytoprotective role of heme oxygenase-1 and heme degradation derived end products in liver injury. World J Hepatol. 2013;5(10):541–549.
   PubMedGoogle Scholar
• Amersi F, Buelow R, Kato H, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest. 1999;104(11):1631–1639.
   PubMed Web of Science ®Google Scholar
• Takeda A, Onodera H, Sugimoto A, et al. Increased expression of heme oxygenase mRNA in rat brain following transient forebrain ischemia. Brain Res. 1994;666(1):120–124.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Terakado M, Horio F, et al. Role of bilirubin as an antioxidant in an ischemia–reperfusion of rat liver and induction of heme oxygenase. Biochem Biophys Res Commun. 1996;223(1):129–135.
   PubMed Web of Science ®Google Scholar
• Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW. Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant. 2004;9(1):84–87.
   Google Scholar
• Ohno K, Ito M, Ichihara M et al. Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev. 2012;353152, 11 pages.
   PubMedGoogle Scholar
• Roberts BW, Mitchell J, Kilgannon JH, et al. Nitric oxide donor agents for the treatment of ischemia/ reperfusion injury in human subjects: a systematic review. Shock. 2013;39(3):229–239.
   PubMed Web of Science ®Google Scholar
• Siriussawakul A, Ahmed Zaky, Lang J D. Role of nitric oxide in hepatic ischemia–reperfusion injury. World J Gastroenterol. 2010;16(48):6079–6086.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Schmid RA, Ando K, et al. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg. 1996;62(3):791–796.
   PubMed Web of Science ®Google Scholar
• Albrecht EW, Stegeman CA, Heeringa P, et al. Protective role of endothelial nitric oxide synthase. J Pathol. 2003;199(1):8–17.
   PubMed Web of Science ®Google Scholar
• Moens AL, Takimoto E, Tocchetti CG, et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation. 2008;117(20):2626–2636.
   PubMed Web of Science ®Google Scholar
• Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009;30:29–41.
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med. 2009;30(1–2):42–59.
   PubMed Web of Science ®Google Scholar
• Knight TR, Ho YS, Farhood A, et al. Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther. 2002 303(2):468–475.
   PubMed Web of Science ®Google Scholar
• Liu P, Fisher MA, Farhood A, et al. Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion. Circ Shock. 1994;43(2):64–70.
   PubMedGoogle Scholar
• Jaeschke H, Farhood A. Neutrophil and Kupffer cell-induced oxidant stress and ischemia–reperfusion injury in rat liver. Am J Physiol. 1991;260(3 Pt 1):G355–G362.
   PubMed Web of Science ®Google Scholar
• Bilzer M, Baron A, Schauer R, et al. Glutathione treatment protects the rat liver against injury after warm ischemia and Kupffer cell activation. Digestion. 2002;66(1): 49–57.
   PubMed Web of Science ®Google Scholar
• Schauer RJ, Kalmuk S, Gerbes AL, et al. Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation. World J Gastroenterol. 2004;10(6):864–870.
   PubMed Web of Science ®Google Scholar
• Prieto-Moure B, Carabén-Redaño A, Aliena-Valero A, et al. Allopurinol in renal ischemia. J Invest Surg. 2014;27:304–316.
   PubMed Web of Science ®Google Scholar
• Perry BC, Soltys D, Toledo AH, et al. “Tumor necrosis factor-α in liver ischemia/reperfusion injury”. J Invest Surg. 2011;24:178–188.
   PubMed Web of Science ®Google Scholar
• Adkins WK, Taylor AE. Role of xanthine oxidase and neutrophils in ischemia–reperfusion injury in rabbit lung. J Appl Physiol. 1990;69(6):2012–2018.
   PubMed Web of Science ®Google Scholar
• Al-Mehdi AB, Shuman H, Fisher AB. Intracellular generation of reactive oxygen species during nonhypoxic lung ischemia. Am J Physiol. 1997;272(2 Pt 1):L294–L300.
   PubMed Web of Science ®Google Scholar
• Kennedy TP, Rao NV, Hopkins C, et al. Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest. 1989;83(4):1326–1335.
   PubMed Web of Science ®Google Scholar
• Zhao G, al-Mehdi AB, Fisher AB. Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol. 1997;273(6 Pt 1):L1112–L1117.
   PubMed Web of Science ®Google Scholar
• Mashiach E, Sela S, Weinstein T, et al. Mesna: a novel renoprotective antioxidant in ischemia acute renal failure. Nephrol Dial Transplant. 2001;16(3):273–276.
   Web of Science ®Google Scholar
• Jaeschke H, Woolbright BL. Current strategies to minimize hepatic ischemia–reperfusion injury by targeting reactive oxygen species. Transplant Rev (Orlando). 2012;26(2):103–114.
   PubMedGoogle Scholar
• Zhu C, Bilali A, Georgieva GS, et al. Salvage of nonischemic control lung from injury by unilateral ischemic lung with apocynin, a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, in isolated perfused rat lung. Transl Res. 2008;152(6):273–282.
   PubMed Web of Science ®Google Scholar
• Dodd O, Pearse DB. Effect of the NADPH oxidase inhibitor apocynin on ischemia–reperfusion lung injury. Am J Physiol Heart Circ Physiol. 2000;279(1):H303–H312.
   PubMed Web of Science ®Google Scholar
• Dinauer MC. The respiratory burst oxidase and the molecular genetics of chronic granulomatous disease. Crit Rev Clin Lab Sci. 1993;30(4):329–369.
   PubMed Web of Science ®Google Scholar
• Heumuller S, Wind S, Barbosa-Sicard E, et al. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51(2):211–217.
   PubMed Web of Science ®Google Scholar
• Chou TC, Lin YF, Wu WC, et al. Enhanced nitric oxide and cyclic GMP formation plays a role in the anti-platelet activity of simvastatin. Br J Pharmacol. 2008;153(6):1281–1287.
   PubMed Web of Science ®Google Scholar
• Gaddam V, Li DH, Mehte JL. Anti-thrombotic effect of atorvastatin-an effect unrelated to lipid lowering. J Cardiovasc Pharmacol Ther. 2002;7(4):247–253.
   PubMedGoogle Scholar
• Lee TS, Chang CC, Zhu Yet al. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 2004;110(10):1296–1302.
   PubMed Web of Science ®Google Scholar
• Yet SF, Tian R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89(2):168–173.
   PubMed Web of Science ®Google Scholar
• Taha MO, Caricati-Neto A, Ferreira RM, et al. L-arginine in the ischemic phase protects against liver ischemia–reperfusion injury. Acta Cir Bras. 2012;27(9):616–623.
   Web of Science ®Google Scholar
• Harward TR, Coe D, Souba WW, et al. Glutamine preserves gut glutathione levels during intestinal ischemia/reperfusion. J Surg Res. 1994;56(4):351–355.
   PubMed Web of Science ®Google Scholar
• Sozen S, Kisakürek M, Yildiz F, et al. The effect of glutamine on hepatic ischemia reperfusion injury in rats. Hippokratia. 2011;15(2):161–166.
   PubMed Web of Science ®Google Scholar
• Chinda K, Chattipakorn & Chattipakon N. Cardioprotective effects of incretin during ischaemia-reperfusion. Diab. Vasc. Dis Res. 2012;9(4):256–269.
   PubMed Web of Science ®Google Scholar
• Mason J. Vitamins and trace elements in the critically ill patient. In: Nutritional Considerations in the Intensive Care Unit: Science, Rationale and Practice. Shikora S, Martindale R, Schwaitzberg, S, Eds. Iowa (USA): Kendall/Hunt Publishing Company. 2002;61–79.
   Google Scholar
• Mallick IH, Winslet MC, Seifalian AM. Pyrrolidine dithiocarbamate protects the small bowel from warm ischaemia/reperfusion injury of the intestine: the role of haem oxygenase. Clin Sci (Lond). 2006;111(6): 373–380.
   PubMed Web of Science ®Google Scholar
• Tian XF, Yao JH, Li YH, et al. protective effect of pyrrolidine dithiocarbamate on liver injury induced by intestinal ischemia–reperfusion in rats. Hepatobiliary Pancreat Dis Int. 2006;5(1):90–95.
   PubMedGoogle Scholar
• Isselhard W, Eitenmúller J, Mäurer W, et al. Increase in myocardial adenine nucleotides induced by adenosine: dosage, mode of application and duration, species differences. J Mol Cell Cardiol. 1980;12(6):619–634.
   PubMed Web of Science ®Google Scholar
• Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation. 1992;85(3):893–904.
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P. Myocardial ischemia–reperfusion injury: Possible role of melatonin. World Cardiol. 2010;2(8):233–236.
   PubMedGoogle Scholar
• Petrosillo G, Moro N, Ruggiero FM, et al. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition an cytochrome c release. Free Radic Biol Med. 2009;47: 969–974.
   PubMed Web of Science ®Google Scholar
• Lochner A, Huisamen B, Nduhirabandi F. Cardioprotective effect of melatonin against ischemia/reperfusion damage. Front Biosci (Elite Ed). 2013;5:305–315.
   PubMedGoogle Scholar
• Verma R, Mishra V, Sasmal D, et al. Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur J Pharmacol. 2010;638(1–3):65–71.
   PubMed Web of Science ®Google Scholar
• Altas M, Meydan S, Aras M, et al. Effects of ceftriaxone on ischemia/reperfusion injury in rat brain. J Clin Neurosci. 2013;20(3):457–461.
   PubMed Web of Science ®Google Scholar
• High WA. Medicolegal aspects of dermatology. Semin Cutan Med Surg. 2013;32(4):183–184.
   PubMed Web of Science ®Google Scholar
• Ota Y, Kuyotaka K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract-role of free radicals and attenuation by captopril. Atherosclerosis. 1997;131(2):195–202.
   PubMed Web of Science ®Google Scholar
• De-Cavanagh EM, Inserra F, Fraga CG. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol Integr Comp Physiol. 2000;278(3):R572–R577.
   PubMed Web of Science ®Google Scholar
• Djordjevic VB, Pavlovic D, Pejovic M, et al. Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors. Clin Nephrol. 1997;47(4):243–247.
   PubMed Web of Science ®Google Scholar
• Khaper N, Singal PK. Effects of after load-reducing drugs on pathogenesis of antioxidant changes and congestive heart failure in rats. J Am Coll Cardiol. 1997;29(4): 856–861.
   PubMed Web of Science ®Google Scholar
• Noda Y, Mori A, Parker L. Free radical scavenging properties of alacepril metabolites and lisinopril. Res Commun Mol Pathol Pharmacol. 1997;96(2):125–136.
   PubMed Web of Science ®Google Scholar
• Anderson B, Khaper N, Dhalla AK, et al. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts. Can J Cardiol. 1996;12(10):1099–1104.
   PubMed Web of Science ®Google Scholar
• Bagchi D, Prasad R, Das DK. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun. 1989;158(1): 52–57.
   PubMed Web of Science ®Google Scholar
• Chopra M, Scott N, McMurray J, et al. Captopril: a free radical scavenger. Br J Pharmacol 1989;27:396–397.
   Web of Science ®Google Scholar
• De-Cavanagh EM, Inserra F, Ferder L, et al. Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS Lett. 1995;361(1):22–24.
   PubMed Web of Science ®Google Scholar
• Güllüoglu BM, Aktan AO, Yegen C, et al. Endothelin release is augmented with captopril in rat ischemia–reperfusion of the liver. Res Exp Med (Berl). 1996;196(4):227–233.
   PubMedGoogle Scholar
• Ross SD, Kron IL, Gangemi JJ, et al. Attenuation of lung reperfusion injury after transplantation using an inhibitor of nuclear factor-κB. Am J Physiol Lung Cell Mol Physiol. 2000;279(3):L528–L536.
   PubMed Web of Science ®Google Scholar
• Molinero LL, Alegre ML. Role of T cell-NF-κB in transplantation. Transplant Rev (Orlando). 2012:26(3):189–200.
   PubMedGoogle Scholar
• Chiang CH, Pai HI, Liu SL. Ventilator-induced lung injury (VILI) promotes ischemia/reperfusion lung injury (I/R) and NF-kappaB antibody attenuates both injuries. Resuscitation. 2008;79(1):147–154.
   PubMed Web of Science ®Google Scholar
• Krishnadasan B, Naidu B, Rosengart M, et al. Decreased lung ischemia–reperfusion injury in rats after preoperative administration of cyclosporine and tacrolimus. J Thorac Cardiovasc Surg. 2002;123(4):756–767.
   PubMed Web of Science ®Google Scholar
• Ishii M, Suzuki Y, Takeshita K, et al. Inhibition of c-Jun NH2-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol. 2004;172(4):2569–2577.
   PubMed Web of Science ®Google Scholar
• Bennett BL, Sasaki DT, Murray BW, et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A. 2001;98(24):13681–13686.
   PubMed Web of Science ®Google Scholar
• Ozaki KS, Kimura S, Murase N. Use of carbon monoxide in minimizing ischemia reperfusion injury in transplantation. Transplant Rev. 2012;26(2):125–139.
   Web of Science ®Google Scholar
• Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391(6662):82–86.
   PubMed Web of Science ®Google Scholar
• Ricote M, Li AC, Willson TM, et al.. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391(6662):79–82.
   PubMed Web of Science ®Google Scholar
• Ito K, Shimada J, Kato D, et al. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia–reperfusion injury in rats. Eur J Cardiothorac Surg. 2004;25(4):530–536.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhu QW, Ye P, et al. Pioglitazone attenuates myocardial ischemia–reperfusion injury via up-regulation of ERK and COX-2. Biosci Trends. 2012;6(6):325–332.
   PubMed Web of Science ®Google Scholar
• Petrat F, Drowatzky J, Boengler K, et al. Protection from glycine at low doses in ischemia–reperfusion injury of the rat small intestine. Eur Surg Res. 2011;46: 180–187.
   PubMed Web of Science ®Google Scholar
• Aldemir M, Boşnak M, Al B, et al.. Effects of molsidomine and lexipafant in hepatic ischemia–reperfusion injury. Injury. 2004;35(3):232–237.
   PubMed Web of Science ®Google Scholar
• Naidu BV, Krishnadasan B, Farivar AS, et al. Early activation of the alveolar macrophage is critical to the development of lung ischemia–reperfusion injury. J Thorac Cardiovasc Surg. 2003;126(1):200–207.
   PubMed Web of Science ®Google Scholar
• Zhao M, Fernandez LG, Doctor A, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia–reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L1018–L1026.
   PubMed Web of Science ®Google Scholar
• Naidu BV, Krishnadasan B, Byrne K, et al. Regulation of chemekine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann Thorac Surg. 2002;74(3):899–905.
   PubMed Web of Science ®Google Scholar
• Mizutani A, Okajima K, Uchiba M, et al. Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte antivation through promotion of prostacyclin production. Blood. 2003;101(8):3029–3036.
   PubMed Web of Science ®Google Scholar
• Zambas NA, Karkos CD, Kambaroudis AG, et al. Protective effect of antithrombin III against lung and myocardial injury in lower-limb ischemia–reperfusion syndrome. Ann Vasc Surg. 2012;26(4):566–570.
   PubMed Web of Science ®Google Scholar
• Goto T, Ishizaka A, Kobayashi F, et al. Importance of tumor necrosis factor-alpha cleavage process in post-transplantation lung injury in rats. Am J Respir Crit Care Med. 2004;170(11):1239–1246.
   PubMed Web of Science ®Google Scholar
• Khimenko PL, Bagby GJ, Fuseler J, et al. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol (1985). 1998;85(6):2005–2011.
   PubMed Web of Science ®Google Scholar
• Genovés P, García D, Cejalvo D, et al. Pentoxyfilline in liver ischemia and reperfusion. J Invest Surg. 2013;27:114–124.
   PubMed Web of Science ®Google Scholar
• Eun BL, Liu XH, Barks JD. Pentoxifylline attenuates hypoxic-ischemic brain injury in immature rats. Pediatr Res. 2000;47(1):73–78.
   PubMed Web of Science ®Google Scholar
• Clark SC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21:225–228.
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhang L, Jia H, et al. Pentoxifylline inhibits endotoxin-induced NF-kappa B activation and associated production of proinflammatory cytokines. Ann Clin Lab Sci. 2004;34(4):427–436.
   PubMed Web of Science ®Google Scholar
• Lloris Carsi JM, Cejalvo Lapeña D, et al. Pentoxifylline protects the small intestine after severe ischemia and reperfusion. Exp Clin Transplant. 2013;11(3): 250–258.
   PubMed Web of Science ®Google Scholar
• Davila-Esqueda ME, Martinez-Morales F. Pentoxifylline diminishes the oxidative damage to renal tissue induced by streptozotocin in the rat. Exp Diabesity Res. 2004;5(4):245–251.
   PubMedGoogle Scholar
• Guggilam A, Haque M, Kerut EK, et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympatho-excitation in heart failure rats. Am J Physiol Heart Circ Physiol. 2007;293(1):H599–H609.
   PubMed Web of Science ®Google Scholar
• Sirin BH, Yilik L, Coskun E, et al. Pentoxifylline reduces injury of the brain in transient ischemia. Acta Cardiol. 1998;53(2):89–95.
   PubMed Web of Science ®Google Scholar
• Thabut G, Brugiere O, Leseche G, et al. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation. Transplantation. 2001;71(9):1295–1300.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu YJ, Mengi SA, et al. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases. Exp Clin Cardiol. 2004;9(2):103–111.
   PubMedGoogle Scholar
• Ciuffetti G, Mercuri M, Ott C, et al. Use of pentoxifylline as a inhibitor of free radical generation in peripheral vascular disease. Eur J Clin Pharmacol. 1991;41(6):511–515.
   PubMed Web of Science ®Google Scholar
• Chapelier A, Reignier J, Mazmanian M, et al. Pentoxifylline and lung ischemia–reperfusion injury: application to lung transplantation. J. Cardiovasc. Pharmacol. 1995;25(Suppl 2):S130–S133.
   PubMed Web of Science ®Google Scholar
• Adams JG Jr, Dhar A, Shukla SD, et al. Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia–reperfusion injury. J. Vasc Surg. 1995;21(5):742–748.
   PubMed Web of Science ®Google Scholar
• Berens KL, Luke DR. Pentoxifylline in the isolated perfused rat kidney. Transplantation. 1990;49(5):876–879.
   PubMed Web of Science ®Google Scholar
• Myers SI, Horton JW, Hernandez R, et al. Pentoxifylline protects splanchnic prostacyclin synthesis during mesenteric ischemia/reperfusion. Prostaglandins. 1994;47(2):137–150.
   PubMed Web of Science ®Google Scholar
• Ege T, Arar C, Canbaz S, et al. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery. Thorac Cardiovasc Surg. 2004;52(1):10–15.
   PubMed Web of Science ®Google Scholar
• Hishikari K, Suzuki J, Ogawa M, et al. Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. Cardiovasc Res. 2009;81(1):123–132.
   PubMed Web of Science ®Google Scholar
• Kazar R, MacQuiggan M. Nutritional support in trauma patients. In: Nutritional Considerations in the Intensive Care Unit: Science, Rationale and Practice. Shikora S, Martindale R, Schwaitzberg, S, eds. Iowa (USA): Kendall/Hunt Publishing Company; 2002;229–244.
   Google Scholar
• Mora, R. Inmunonutrición. In: Soporte Nutricional Especial. Bogotá: Panamericana Ed; 2000;338–341.
   Google Scholar